Therapeutic Advances in Vaccines and Immunotherapy
| Philip Shaw | SAGE Publications Ltd, London, UK |
Journal Highlights
- Launched in 2013
- Gold open access journal – all articles are made freely available online immediately upon publication
- Rigorous peer review
- Listed in PubMed
- Free to publish in for an introductory period
Therapeutic Advances in Vaccines and Immunotherapy is a peer-reviewed open access journal which focuses on all areas of vaccinology and immunotherapy, reporting on both prophylactic and therapeutic vaccination as well as an ever-growing repertoire of other immunotherapeutic interventions. Please see the aims and scope for further information.
Diversity, Equity and Inclusion Statement
Therapeutic Advances in Vaccines and Immunotherapy promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the research community.
Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.
We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.
We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.
Submission information
Submit your manuscript today at https://mc.manuscriptcentral.com/tav.
Please see the submission guidelines tab for more information on how to submit your article to the journal.
Open access information
The article processing charge (APC) is $2,800 USD, currently discounted to a rate of $1,400 USD. The APC for a Plain Language Summary is $4,500 USD.
Contact
Please direct any queries to philip.shaw@sagepub.co.uk.
This journal changed its publication mode from subscription to open access in 2019.
Therapeutic Advances in Vaccines and Immunotherapy covers themes including but not limited to:
- Immunotherapy for Cancer
- Vaccine Development
- Personalised Immunotherapy
- Vaccine Adjuvants and Formulation
- Immunotherapeutic Targets
- Immunotherapy and Autoimmune Diseases
- Vaccine Delivery Systems
- Immune Response Monitoring
- Vaccination Strategies in low-resource settings
- Vaccine strategies in emerging Infectious Diseases
- Ethical and Regulatory Considerations
- Global Health policies on Access to Vaccines
- Vaccine Hesitancy and Communication
- Immune Memory and Long-Term Protection
- Vaccine Safety and Adverse Events
| Bushra Mahdi | Sage Publications Ltd, United Kingdom |
| Ashwini Navnath Nikam | Sage Publications Ltd, India |
| Christopher S. Ambrose | AstraZeneca, Washington DC, USA |
| Said Dermime | National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar |
| E. David G. McIntosh | Imperial College, London, UK |
| Peter L. Stern | University of Manchester, Manchester, UK |
| Mark Alderson | Path, Seattle, USA |
| Shai Ashkenazi | Schneider Children’s Medical Center of Israel, Petah Tikva, Israel |
| Stan L. Block | Kentucky Pediatric and Adult Research Inc., Bardstown, KY, United States |
| Paolo Bonanni | Public Health Department, University of Florence, Florence, Italy |
| Robert Booy | Children's Hospital Westmead, The University of Sydney, NSW, Australia |
| Rodrigo DeAntonio | CEVAXIN, Panama City, Panama |
| Susanna Esposito | Università degli Studi di Perugia, Perugia, Italy |
| Alison N. Fiander | School of Medicine, Cardiff University, Cardiff, UK |
| Suzanne M. Garland | The Royal Women’s Hospital, Parkville, Australia |
| Jamie Honeychurch | The University of Manchester, UK |
| Samir Khleif | Augusta University, USA |
| Matti Lehtinen | University of Tampere, School of Public Health, Tampere, Finland |
| Helen S. Marshall | Women’s and Children’s Hospital, University of Adelaide, SA, Australia |
| Cornelis Melief | Leiden University Medical Center, The Netherlands |
| Adrian Onu | Cantacuzino National Medico-Military Research and Development Institute, Bucharest, Romania |
| Eun Jeong Park, PhD | Mie University Graduate School of Medicine, Japan |
| Sanjay Phogat | Sanofi Pasteur, Swiftwater, PA, USA |
| Heinz-Josef Schmitt | Pfizer, Paris, France |
| Bart Tarbet | Utah State University, USA |
| Miriam Tendler | Institute Oswaldo Cruz, Manguinhos, Rio de Janeiro, Brasil, Brazil |
| Usa Thisyakorn | Faculty of Engineering, Mahidol University, Thailand |
| Wiebren Tjalma | Antwerp University Hospital, Edegem, Belgium |
| Sudhanshu Vrati | Regional Centre for Biotechnology, Faridabad, India |
| Fernando Monteiro Aarestrup, MD, PhD | SUPREMA -Juiz de Fora MG , Brazil |
| Dr. Shahid M. Baba, Ph.D | Islamic University of Science & Technology, Kashmir, India |
| Abdelaali Balahbib | High Institute of Nursing Professions and Health Techniques of Errachidia, Errachidia, Morocco |
| Lorena G. Barberia, PhD | University of Sao Paulo, Brazil |
| Lalit Batra, PhD | University of Louisville , USA |
| Pooya Farhangnia, MSc. | Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran |
| Karin Hellner | Oxford University Hospitals NHS Foundation Trust, UK |
| AVINASH KUNDADKA KUDVA, MSc, PhD | Penn State College of Medicine, USA |
| Ivette Ariela Nunez, PhD | NIH/NIAID Integrated Research Facility at Fort Detrick, Frederick, MD, USA |
| Dr. Ika Nurlaila, M.H.Sc | National Research and Innovation Agency (BRIN), Indonesia |
| Adile Orhan, MD, PhD | Zealand University Hospital, Denmark |
| Mohammed Rohaim ,PhD | Lancaster University, UK |
| Balamurugan Shanmugaraj | Bharathiar University, India |
| Debolina Sinha, Ph.D | Vidyasagar College, Kolkata, West Bengal |
| Nishanth Thalambedu, MD | University of Arkansas for Medical Sciences, Little Rock, AR, USA |
Manuscript submission guidelines can be accessed on Sage Journals.